Patents Archives -

Exclusive interview with expert speaker from ASBM

Exclusive Interview with ASBM Released Ahead of Upcoming Biosimilars Conference

https://pharmaphorum.com/partner-content/exclusive-interview-with-asbm-released-ahead-of-upcoming-biosimilars-conference/

News/ News/ R&D

UK pharma patents up 20%, new report finds

George Underwood EPO, Europe, Innovation, Patents, UK 0 Comment

The pharma industry saw double-digit growth in patent filings for the second year in a row in 2018,

UK pharma patents up 20%, new report finds

https://pharmaphorum.com/news/uk-pharma-patents-up-20-new-report-finds/

Market Access/ News/ News

Teva and Neos settle over Cotempla patent dispute

George Underwood ADHD, Neos, Patents, Teva 0 Comment

Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over

Teva and Neos settle over Cotempla patent dispute

https://pharmaphorum.com/news/teva-and-neos-settle-over-cotempla-patent-dispute/

Market Access/ Views & Analysis/ Views and analysis

Will plausibility reign supreme in Lyrica second medical use patent case?

Linda Banks Legal, Patents, pharma law, plausibility 0 Comment

Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.

Will plausibility reign supreme in Lyrica second medical use patent case?

https://pharmaphorum.com/views-analysis-market-access/will-plausibility-reign-supreme-in-lyrica-second-medical-use-patent-case/

Market Access/ Views and analysis

Local partnerships key to pharma’s success in China

Linda Banks China, Intellectual property, IP, Patents, pharma in China 0 Comment

China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.

Local partnerships key to pharma’s success in China

https://pharmaphorum.com/views-and-analysis/local-partnerships-key-pharmas-success-china/

News/ News/ Pfizer/ Pharma Market Access/ R&D

Biotech association steps in to fight growth of ‘plausibility’ patent challenges

Andrew McConaghie Actavis, BIA, Patents, Pfizer, UK biotech 0 Comment

The UK’s Supreme Court is to allow the UK BioIndustry Association (BIA) to intervene in a long-running legal

Biotech association steps in to fight growth of ‘plausibility’ patent challenges

https://pharmaphorum.com/news/biotech-association-steps-fight-growth-plausibility-patent-challenges/

Articles/ Deep Dive/ Pharma Market Access/ Views and analysis

Increasing access to medicines: A critical look at pharmaceutical patents

Linda Banks access to medicines, drug patents, Patents, pharma patents 0 Comment

Extending patents is restricting patients’ access to the treatments they need.

Increasing access to medicines: A critical look at pharmaceutical patents

https://pharmaphorum.com/views-and-analysis/increasing-access-to-medicines-a-critical-look-at-pharmaceutical-patents/

Articles/ R&D/ US/ Views and analysis

Making the case for pharmaceutical IP management

Marco Ricci generics, Intellectual property, IP, Law, Legal, Patents 0 Comment

IP management can protect pharma companies’ investments and future R&D.

Making the case for pharmaceutical IP management

https://pharmaphorum.com/views-and-analysis/making-case-pharmaceutical-ip-management/

Articles/ Pharma Market Access/ US/ Views and analysis

Recent trends in ANDA litigation

Marco Ricci Abbreviated New Drug Applications, ANDA, generics, Intellectual property, IP, litigation, Patents 0 Comment

Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.

Recent trends in ANDA litigation

https://pharmaphorum.com/views-and-analysis/recent-trends-anda-litigation/

Trending

Patents

Login